LifeVantage Co. (LFVN) to Issue Quarterly Dividend of $0.04 on December 16th

LifeVantage Co. (NASDAQ:LFVN) announced a quarterly dividend on Tuesday, October 29th, Zacks reports. Shareholders of record on Monday, December 2nd will be paid a dividend of 0.04 per share on Monday, December 16th. This represents a $0.16 dividend on an annualized basis and a yield of 1.23%. The ex-dividend date is Monday, December 2nd.

LifeVantage has a dividend payout ratio of 22.2% indicating that its dividend is sufficiently covered by earnings.

LifeVantage Stock Performance

Shares of LFVN stock opened at $13.00 on Thursday. The company has a market capitalization of $165.11 million, a price-to-earnings ratio of 46.18 and a beta of 0.84. LifeVantage has a 52-week low of $4.20 and a 52-week high of $14.71. The company has a 50-day simple moving average of $10.86 and a two-hundred day simple moving average of $8.35.

LifeVantage (NASDAQ:LFVN) last released its earnings results on Tuesday, October 29th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. The firm had revenue of $47.21 million for the quarter. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.